Tuesday, June 30, 2026

North Korea’s Victory Over a Russian Athlete, North Korea’s Olympic Team Expands its Roster

North Korea's Oh Kyong-ryong wins gold in women's freestyle 55 kg at the World Wrestling Championships in Croatia, marking the nation's second medal.

Global Tech Regulations: U.S. Stands Firm Against South Korea’s Claims

The CCIA, a global IT organization representing...

NewJeans Reaches a Turning Point, Reveals New Name NJZ Amid Legal Battle

K-pop group NewJeans announces their new name NJZ and plans independent activities amid a legal dispute with ADOR and HYBE.

Tag: ST Pharm

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm showcased its CDMO capabilities at TIDES USA and ASGCT 2026, focusing on nucleic acid therapeutics and strategic partnerships.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Top News

- Our Sponsors Ad -

Follow us